期刊文献+

抗真菌药物作用靶位的研究进展 被引量:3

下载PDF
导出
摘要 发展新型抗真菌药物的关键是发现和鉴定致病性真菌生物合成或分子作用靶位。目前主要通过分析真菌结构成分及代谢产物,研究真菌成分生物合成途径及其相关酶分子以及了解控制真菌生长物和分裂的基因序列来发现作用于真菌的靶位。随着对抗真菌作用靶位的深入研究,在不久将来会产生更加安全、有效的抗真菌新药,对改善各种真菌感染预后带来希望,本文就抗真菌药物作用靶位的研究现状综述如下。
作者 郝飞 叶庆佾
出处 《中国皮肤性病学杂志》 CAS 北大核心 2001年第2期123-124,共2页 The Chinese Journal of Dermatovenereology
  • 相关文献

参考文献10

  • 1[1]Groll AH, Lucca AJD, Walsh TJ. Emerging targets for the development of novel antifungal therapeutics [J]. Trend Microbiol,1998,6(3): 117~ 124
  • 2[2]Maertens JA, Boogaoerts MA. Fungal cell wall inhibitors emphasis on clinical aspects [J ]. Curr Pharm Des, 2000,6 (2): 225 ~239
  • 3[3]Kollar R, Reinhold BB, Petrakova E, et al.Architecture of the yeast cell wall. Beta( l-6)-glucan interconnects manoprotein, beta ( 1-3)-glucan, and chitin [ J ]. J Biol Chem,1997,272(28): 17762~17775
  • 4[4]Groll AH, Piscitelli SC, Walsh TJ. Clinical pharmacology of systemic antifungal agents:a comprehensive review of agents in clinical use, current investigational compounds, and putative targets for antifungal drug development [J ]. Adv Pharmatol,1998,44(2) :343 ~500
  • 5[5]Hanada K, Nishijima M, Fujita T, et al.Specificity of inhibitors of serine palmitoytransferase(SPT), a key enzyme in sphingolipid biosynthesis in infect cells. A novel evaluation system using an SPT-defective mammalian cell mutant [ J]. Biochem Pharmacol,2000,59(10). 1211 ~ 1216
  • 6[6]Mandalal SM, Harris GH. Isolation and characterization of novel inhibitors of sphingolipid synthesis: australifungin, viridiofungin, rustmicin, and Khafrefungin[J ]. Methods Enzymol, 2000,311 (3): 335 ~ 348
  • 7[7]In Y, Ishida T,Takesako K. Unique molecular conformation of aureobasidin A, a highly amide N methy lated cyclic depsipeptide with potent antifungal activity: X - ray crystal structure and molecular modeling studies[ J ]. J Pept Res, 1999,531 (3): 492~500
  • 8[8]Derlin DS, Seto- Yong D, Monk BC. The plasma membrane H -ATPase of fungi. A candidate drug targets[J ]? Ann N Y Acad Sci, 1997,834(3). 609 ~617
  • 9[9]Ahmad I, Perkins WR, Lupan DM, et al.Liposomal entrapment of the neutrophil-derived peptide indolicidin endows it with in vivo antifungal activity[J]. Biochim Biophys Acta, 1995, 1237(2): 109 ~ 114
  • 10[10]Persidis A. Antibacterial and antifungal drug discovery [J ]. Nat Biotechnol, 1999,17(11):1141 ~1142

同被引文献50

  • 1肖业臣,温硕洋,黄亚东,杨婉莹,曹阳.昆虫抗菌肽和抗真菌肽结构与功能的关系及分子设计[J].昆虫学报,2004,47(5):659-669. 被引量:13
  • 2Kelly SL,Lamb DC,Corran AJ,et al.Model of action and resistance to azole antifungals associated with the formation of 14α-methylergosta-8,24(28)-dien-3β,6α-diol[J].Biochem Biophys Res Commun,1995,207(3)∶910-915.
  • 3Georgopapadakou N,Walsh TJ.Antifungal agents:chemotherapeutic targets and immunoligic strategies[J].Antimicrob Agents Chemother,1996,40(2)∶279-291.
  • 4Ghannoum MA,Rice LB.Antifungal agents:mode of action,mechanisms of resitance,and correlation of these mechanisms with bacterial resistance[J].Clin Microbiol Rev,1999,12(4)∶501-517.
  • 5Holz RW.The effects of polyene antibiotics nystain and amphotericin B on the lipid membranes[J].Ann NY Acad Sci,1974,235(10)∶469-479.
  • 6Hsuchen CC,Feingold DF.Polyene antibiotic action on lecithin liposomes:effect of cholesterol and fatty acyl chains[J].Biochem Biophys Res Commun,1973,51(5)∶972-978.
  • 7Hugo VB.Mechanism of antifungal resistance[J].Rev Iberoam Micol,1997,14(1)∶44-49.
  • 8Michaelis S,Berkower C.Sequence comparison of yeast ATP binding cassette(ABC) proteins[J].Cold Spring Harbor Symp Quant Biol,1995,60∶291-307.
  • 9Hiemenz JW,Walsh TJ.Lipid formulations of amphotericin B[J].J Liposome Res,1998,8(5)∶443-467.
  • 10Rowles DM,Fraser SL.Amphotericin B lipid complex(ABLC)-associated hypertension:case report and review[J].Clin Infect Dis,1999,29(6)∶1564-1565.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部